Stereotactic Partial Breast Irradiation in Primary Breast Cancer: A Comprehensive Review of the Current Status and Future Directions

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Oct 31

PMID 36313648

Authors

Silvia Takanen

Paola Pinnaro

Ilaria Farina

Francesca Sperati

Claudio Botti

Patrizia Vici

Antonella Soriani

Laura Marucci

Giuseppe Sanguineti

Affiliations

Soon will be listed here.

Abstract

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021257856, identifier CRD42021257856.

Citing Articles

Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study.

Chen G, Gu X, Xue J, Zhang X, Yu X, Zhang Y Elife. 2023; 12.

PMID: 38131294 PMC: 10746137. DOI: 10.7554/eLife.91737.

A deep learning approach for automatic delineation of clinical target volume in stereotactic partial breast irradiation (S-PBI).

Kazemimoghadam M, Yang Z, Chen M, Rahimi A, Kim N, Alluri P Phys Med Biol. 2023; 68(10).

PMID: 37084739 PMC: 10325028. DOI: 10.1088/1361-6560/accf5e.

References

Wahl D, Stenmark M, Tao Y, Pollom E, Caoili E, Lawrence T . Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. J Clin Oncol. 2015; 34(5):452-9. PMC: 4872011. DOI: 10.1200/JCO.2015.61.4925. View

Orecchia R, Veronesi U, Maisonneuve P, Galimberti V, Lazzari R, Veronesi P . Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021; 22(5):597-608. DOI: 10.1016/S1470-2045(21)00080-2. View

Henderson L, Craig J, Willis N, Tovey D, Webster A . How to write a Cochrane systematic review. Nephrology (Carlton). 2010; 15(6):617-24. DOI: 10.1111/j.1440-1797.2010.01380.x. View

Herman J, Chang D, Goodman K, Dholakia A, Raman S, Hacker-Prietz A . Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer. 2014; 121(7):1128-37. PMC: 4368473. DOI: 10.1002/cncr.29161. View

Pinnaro P, Arcangeli S, Giordano C, Arcangeli G, Impiombato F, Pinzi V . Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol. 2011; 6:155. PMC: 3229442. DOI: 10.1186/1748-717X-6-155. View

Kirby A . Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial?. Br J Radiol. 2018; 91(1085):20170565. PMC: 6190767. DOI: 10.1259/bjr.20170565. View

Widmark A, Gunnlaugsson A, Beckman L, Thellenberg-Karlsson C, Hoyer M, Lagerlund M . Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet. 2019; 394(10196):385-395. DOI: 10.1016/S0140-6736(19)31131-6. View

de Geus S, Eskander M, Kasumova G, Ng S, Kent T, Mancias J . Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Cancer. 2017; 123(21):4158-4167. DOI: 10.1002/cncr.30856. View

Blitzblau R, Arya R, Yoo S, Baker J, Chang Z, Palta M . A phase 1 trial of preoperative partial breast radiation therapy: Patient selection, target delineation, and dose delivery. Pract Radiat Oncol. 2015; 5(5):e513-e520. PMC: 4568137. DOI: 10.1016/j.prro.2015.02.002. View

10.

Deeks J . Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001; 323(7305):157-62. PMC: 1120791. DOI: 10.1136/bmj.323.7305.157. View

11.

Nikitas J, DeWees T, Rehman S, Abraham C, Bradley J, Robinson C . Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers. Clin Lung Cancer. 2018; 20(2):107-116. PMC: 6387838. DOI: 10.1016/j.cllc.2018.10.010. View

12.

Rahimi A, Zhang Y, Kim D, Morgan H, Hossain F, Leitch M . Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial. Int J Radiat Oncol Biol Phys. 2020; 108(3):697-706. DOI: 10.1016/j.ijrobp.2020.05.025. View

13.

Snider J, Mutaf Y, Nichols E, Hall A, Vadnais P, Regine W . Dosimetric Improvements with a Novel Breast Stereotactic Radiotherapy Device for Delivery of Preoperative Partial-Breast Irradiation. Oncology. 2016; 92(1):21-30. DOI: 10.1159/000449388. View

14.

Seiler S, Rahimi A, Choudhery S, Garwood D, Spangler A, Cherian S . Ultrasound-Guided Placement of Gold Fiducial Markers for Stereotactic Partial-Breast Irradiation. AJR Am J Roentgenol. 2016; 207(3):685-8. DOI: 10.2214/AJR.15.14771. View

15.

Rahimi A, Morgan H, Kim D, Zhang Y, Leitch M, Wooldridge R . Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2021; 110(3):772-782. DOI: 10.1016/j.ijrobp.2021.01.015. View

16.

Cox B, Horst K, Thornton S, Dirbas F . Impact of increasing margin around the lumpectomy cavity to define the planning target volume for 3D conformal external beam accelerated partial breast irradiation. Med Dosim. 2007; 32(4):254-62. DOI: 10.1016/j.meddos.2007.02.003. View

17.

Presley C, Soulos P, Herrin J, Roberts K, Yu J, Killelea B . Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol. 2012; 30(35):4302-7. PMC: 3675700. DOI: 10.1200/JCO.2012.43.5297. View

18.

Yu C, Shao X, Zhang J, Regine W, Zheng M, Yu Y . GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer. Med Phys. 2013; 40(5):051703. PMC: 3637326. DOI: 10.1118/1.4798961. View

19.

Strauss J, Dickler A . Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. Radiother Oncol. 2009; 91(2):157-65. DOI: 10.1016/j.radonc.2008.12.014. View

20.

Polgar C, Major T, Fodor J, Sulyok Z, Somogyi A, Lovey K . Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol. 2010; 94(3):274-9. DOI: 10.1016/j.radonc.2010.01.019. View